Zhejiang Shengda Bio-Pharm Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 579.71 million compared to CNY 666.88 million a year ago. Revenue was CNY 579.71 million compared to CNY 666.88 million a year ago. Net income was CNY 63.97 million compared to CNY 200.41 million a year ago. Basic earnings per share from continuing operations was CNY 0.37 compared to CNY 1.19 a year ago. Diluted earnings per share from continuing operations was CNY 0.37 compared to CNY 1.13 a year ago.